Literature DB >> 8094395

Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages.

L Z Pan1, A Werner, J A Levy.   

Abstract

Free virus (virus not present within cells) was detected in the plasma of all human immunodeficiency virus (HIV)-infected individuals studied. Plasma samples from asymptomatic individuals and individuals with HIV disease were tested. The levels of virus varied, but high virus titers correlated directly with HIV-related symptoms and low CD4+ lymphocyte counts. Effective detection of infectious virus depended on the use of an enzyme-linked immunosorbent assay for p24 core antigen and culture conditions in which plasma was added to mitogen-stimulated lymphocytes within 3 h of venipuncture. When there were delays in the time to culturing of plasma, neutralizing antibodies and perhaps other factors present in the plasma were found to reduce the efficiency of virus recovery. Plasma stored at -70 degrees C for several months maintained a stable level of free virus. These results suggest that measurement of HIV present in plasma under optimal conditions could be an efficient way of monitoring the clinical state of an individual and the effects of antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094395      PMCID: PMC262750          DOI: 10.1128/jcm.31.2.283-288.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Plasma viraemia as a marker of viral replication in HIV-infected individuals.

Authors:  S Escaich; J Ritter; P Rougier; D Lepot; J P Lamelin; M Sepetjan; C Trepo
Journal:  AIDS       Date:  1991-10       Impact factor: 4.177

2.  Characterization of HIV-1 neutralization escape mutants.

Authors:  J A McKeating; J Gow; J Goudsmit; L H Pearl; C Mulder; R A Weiss
Journal:  AIDS       Date:  1989-12       Impact factor: 4.177

3.  Detection of infectious immune complexes in human immunodeficiency virus type 1 (HIV-1) infections: correlation with plasma viremia and CD4 cell counts.

Authors:  S A Fiscus; E B Wallmark; J D Folds; J Fryer; C M van der Horst
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

4.  Correlation between CD4 cell counts and cellular and plasma viral load in HIV-1-seropositive individuals.

Authors:  A Venet; W Lu; K Beldjord; J M Andrieu
Journal:  AIDS       Date:  1991-03       Impact factor: 4.177

5.  Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

Authors:  D D Ho; T Moudgil; M Alam
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

6.  High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

Authors:  M S Saag; M J Crain; W D Decker; S Campbell-Hill; S Robinson; W E Brown; M Leuther; R J Whitley; B H Hahn; G M Shaw
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

7.  Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells.

Authors:  B A Castro; C D Weiss; L D Wiviott; J A Levy
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

8.  Plasma viremia in human immunodeficiency virus infection.

Authors:  R W Coombs; A C Collier; J P Allain; B Nikora; M Leuther; G F Gjerset; L Corey
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

9.  Comparative assessment of quantitative HIV viraemia assays.

Authors:  C Rouzioux; J Puel; H Agut; F Brun-Vézinet; F Ferchal; C Tamalet; P Descamps; H Fleury
Journal:  AIDS       Date:  1992-04       Impact factor: 4.177

10.  Rapid and sensitive viral culture method for human immunodeficiency virus type 1.

Authors:  J B Jackson; R W Coombs; K Sannerud; F S Rhame; H H Balfour
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

View more
  20 in total

Review 1.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

2.  Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.

Authors:  J Ferbas; E S Daar; K Grovit-Ferbas; W J Lech; R Detels; J V Giorgi; A H Kaplan
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group.

Authors:  W A Scott; D Brambilla; E Siwak; C Beatty; J Bremer; R W Coombs; H Farzadegan; S A Fiscus; S M Hammer; F B Hollinger; N Khan; S Rasheed; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.

Authors:  H Revets; D Marissens; S de Wit; P Lacor; N Clumeck; S Lauwers; G Zissis
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases).

Authors:  J L Lathey; S A Fiscus; S Rasheed; J C Kappes; B P Griffith; T Elbeik; S A Spector; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

6.  Survival of human immunodeficiency virus in suspension and dried onto surfaces.

Authors:  J van Bueren; R A Simpson; P Jacobs; B D Cookson
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

7.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

8.  Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum.

Authors:  M Schreiber; H Petersen; C Wachsmuth; H Müller; F T Hufert; H Schmitz
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Prospective study of antigenemia, plasma viremia and lymphocytic viremia in HIV-infected hemophiliacs.

Authors:  S Melón Garcia; M de Oña Navarro; C Rodriguez Pinto; M Fernández Urgellés; A Martinez Gutierrez; P de la Iglesia; F J Mendez García
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

Review 10.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.